Plasma Fractionation - Global Market Outlook (2017-2023)

  • ID: 4449942
  • Report
  • Region: Global
  • 156 pages
  • Stratistics Market Research Consulting Pvt Ltd
UP TO OFF
until Jan 31st 2019
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 4

FEATURED COMPANIES

  • Bio Products Laboratory
  • Biotest
  • Csl, Ltd.
  • Grifols International SA
  • Kedrion S.P.A.
  • LFB SA
  • MORE
The Global Plasma Fractionation Market is accounted for $18.14 billion in 2016 and is expected to reach $30.14 billion by 2023 growing at a CAGR of 7.5% during the forecast period. Factors such as rising geriatric population and increasing number of hemophilic patients are boosting the market growth. On the contrary, strict government rules, huge cost and limited reimbursements are some of the factors hampering the market. Rising digit of hemophilic patients is creating growth opportunities for vendors in the market.

By product, immunoglobulin segment witnessed the largest market share during the forecast period. However, protease inhibitors segment is expected to witness the fastest growth rate in the next five years. The growth of this segment is mainly attributed to its increasing use for respiratory diseases and growing application in various diseases.

By region, North America accounted for largest market share followed by Europe due to increasing use of immunoglobulins in neurological diseases and increasing use of prophylaxis treatments for diagnosed patients, and the rising number of registered hemophilic patients in this region.

Some of the key players in global plasma fractionation market include Octapharma AG, Chinese Biological Products, Inc., Bio Products Laboratory, Baxter International, Inc., Csl, Ltd., Grifols International SA, Shanghai Raas Blood Products Co., Ltd, China Biologic Products, Inc., Biotest, Kedrion S.P.A., LFB SA and Sanquin.

Products Covered:
  • Protease Inhibitors
  • Coagulation Factor Concentrates
  • Immunoglobulin
  • Fractionation Process
  • Albumin
  • Other Plasma Products
End Users Covered:
  • Clinical Research Laboratories
  • Academic Institutes
  • Hospitals and Clinics
Applications Covered:
  • Rheumatology
  • Pulmonology
  • Hemato-Oncology
  • Immunology
  • Neurology
  • Critical Care
  • Hematology
  • Other Applications
Regions Covered:
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific
  • South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa
What our report offers:
  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bio Products Laboratory
  • Biotest
  • Csl, Ltd.
  • Grifols International SA
  • Kedrion S.P.A.
  • LFB SA
  • MORE
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Application Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Plasma Fractionation Market, By Product
5.1 Introduction
5.2 Protease Inhibitors
5.3 Coagulation Factor Concentrates
5.3.1 Factor VIII
5.3.2 Factor IX
5.3.3 Factor XIII
5.3.4 Fibrinogen Concentrates
5.3.5 Prothrombin Complex Concentrates
5.3.6 Von Willebrand Factor (VWF)
5.4 Immunoglobulin
5.4.1 Subcutaneous Immunoglobulin
5.4.2 Intravenous Immunoglobulin
5.4.3 Other Immunoglobulins
5.5 Fractionation Process
5.6 Albumin
5.7 Other Plasma Products

6 Global Plasma Fractionation Market, By End User
6.1 Introduction
6.2 Clinical Research Laboratories
6.3 Academic Institutes
6.4 Hospitals and Clinics

7 Global Plasma Fractionation Market, By Application
7.1 Introduction
7.2 Rheumatology
7.3 Pulmonology
7.4 Hemato-Oncology
7.5 Immunology
7.6 Neurology
7.7 Critical Care
7.8 Hematology
7.9 Other Applications

8 Global Plasma Fractionation Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Octapharma AG
10.2 Chinese Biological Products, Inc.
10.3 Bio Products Laboratory
10.4 Baxter International, Inc.
10.5 Csl, Ltd.
10.6 Grifols International SA
10.7 Shanghai Raas Blood Products Co., Ltd
10.8 China Biologic Products, Inc.
10.9 Biotest
10.10 Kedrion S.P.A.
10.11 LFB SA
10.12 Sanquin

List of Tables:
Table 1 Global Plasma Fractionation Market Outlook, By Region (2014-2023) ($MN)
Table 2 Global Plasma Fractionation Market Outlook, By Product (2014-2023) ($MN)
Table 3 Global Plasma Fractionation Market Outlook, By Protease Inhibitors (2014-2023) ($MN)
Table 4 Global Plasma Fractionation Market Outlook, By Coagulation Factor Concentrates (2014-2023) ($MN)
Table 5 Global Plasma Fractionation Market Outlook, By Factor VIII (2014-2023) ($MN)
Table 6 Global Plasma Fractionation Market Outlook, By Factor IX (2014-2023) ($MN)
Table 7 Global Plasma Fractionation Market Outlook, By Factor XIII (2014-2023) ($MN)
Table 8 Global Plasma Fractionation Market Outlook, By Fibrinogen Concentrates (2014-2023) ($MN)
Table 9 Global Plasma Fractionation Market Outlook, By Prothrombin Complex Concentrates (2014-2023) ($MN)
Table 10 Global Plasma Fractionation Market Outlook, By Von Willebrand Factor (VWF) (2014-2023) ($MN)
Table 11 Global Plasma Fractionation Market Outlook, By Immunoglobulin (2014-2023) ($MN)
Table 12 Global Plasma Fractionation Market Outlook, By Subcutaneous Immunoglobulin (2014-2023) ($MN)
Table 13 Global Plasma Fractionation Market Outlook, By Intravenous Immunoglobulin (2014-2023) ($MN)
Table 14 Global Plasma Fractionation Market Outlook, By Other Immunoglobulins (2014-2023) ($MN)
Table 15 Global Plasma Fractionation Market Outlook, By Fractionation Process (2014-2023) ($MN)
Table 16 Global Plasma Fractionation Market Outlook, By Albumin (2014-2023) ($MN)
Table 17 Global Plasma Fractionation Market Outlook, By Other Plasma Products (2014-2023) ($MN)
Table 18 Global Plasma Fractionation Market Outlook, By End User (2014-2023) ($MN)
Table 19 Global Plasma Fractionation Market Outlook, By Clinical Research Laboratories (2014-2023) ($MN)
Table 20 Global Plasma Fractionation Market Outlook, By Academic Institutes (2014-2023) ($MN)
Table 21 Global Plasma Fractionation Market Outlook, By Hospitals and Clinics (2014-2023) ($MN)
Table 22 Global Plasma Fractionation Market Outlook, By Application (2014-2023) ($MN)
Table 23 Global Plasma Fractionation Market Outlook, By Rheumatology (2014-2023) ($MN)
Table 24 Global Plasma Fractionation Market Outlook, By Pulmonology (2014-2023) ($MN)
Table 25 Global Plasma Fractionation Market Outlook, By Hemato-Oncology (2014-2023) ($MN)
Table 26 Global Plasma Fractionation Market Outlook, By Immunology (2014-2023) ($MN)
Table 27 Global Plasma Fractionation Market Outlook, By Neurology (2014-2023) ($MN)
Table 28 Global Plasma Fractionation Market Outlook, By Critical Care (2014-2023) ($MN)
Table 29 Global Plasma Fractionation Market Outlook, By Hematology (2014-2023) ($MN)
Table 30 Global Plasma Fractionation Market Outlook, By Other Applications (2014-2023) ($MN)
Table 31 North America Plasma Fractionation Market Outlook, By Country (2014-2023) ($MN)
Table 32 North America Plasma Fractionation Market Outlook, By Product (2014-2023) ($MN)
Table 33 North America Plasma Fractionation Market Outlook, By Protease Inhibitors (2014-2023) ($MN)
Table 34 North America Plasma Fractionation Market Outlook, By Coagulation Factor Concentrates (2014-2023) ($MN)
Table 35 North America Plasma Fractionation Market Outlook, By Factor VIII (2014-2023) ($MN)
Table 36 North America Plasma Fractionation Market Outlook, By Factor IX (2014-2023) ($MN)
Table 37 North America Plasma Fractionation Market Outlook, By Factor XIII (2014-2023) ($MN)
Table 38 North America Plasma Fractionation Market Outlook, By Fibrinogen Concentrates (2014-2023) ($MN)
Table 39 North America Plasma Fractionation Market Outlook, By Prothrombin Complex Concentrates (2014-2023) ($MN)
Table 40 North America Plasma Fractionation Market Outlook, By Von Willebrand Factor (VWF) (2014-2023) ($MN)
Table 41 North America Plasma Fractionation Market Outlook, By Immunoglobulin (2014-2023) ($MN)
Table 42 North America Plasma Fractionation Market Outlook, By Subcutaneous Immunoglobulin (2014-2023) ($MN)
Table 43 North America Plasma Fractionation Market Outlook, By Intravenous Immunoglobulin (2014-2023) ($MN)
Table 44 North America Plasma Fractionation Market Outlook, By Other Immunoglobulins (2014-2023) ($MN)
Table 45 North America Plasma Fractionation Market Outlook, By Fractionation Process (2014-2023) ($MN)
Table 46 North America Plasma Fractionation Market Outlook, By Albumin (2014-2023) ($MN)
Table 47 North America Plasma Fractionation Market Outlook, By Other Plasma Products (2014-2023) ($MN)
Table 48 North America Plasma Fractionation Market Outlook, By End User (2014-2023) ($MN)
Table 49 North America Plasma Fractionation Market Outlook, By Clinical Research Laboratories (2014-2023) ($MN)
Table 50 North America Plasma Fractionation Market Outlook, By Academic Institutes (2014-2023) ($MN)
Table 51 North America Plasma Fractionation Market Outlook, By Hospitals and Clinics (2014-2023) ($MN)
Table 52 North America Plasma Fractionation Market Outlook, By Application (2014-2023) ($MN)
Table 53 North America Plasma Fractionation Market Outlook, By Rheumatology (2014-2023) ($MN)
Table 54 North America Plasma Fractionation Market Outlook, By Pulmonology (2014-2023) ($MN)
Table 55 North America Plasma Fractionation Market Outlook, By Hemato-Oncology (2014-2023) ($MN)
Table 56 North America Plasma Fractionation Market Outlook, By Immunology (2014-2023) ($MN)
Table 57 North America Plasma Fractionation Market Outlook, By Neurology (2014-2023) ($MN)
Table 58 North America Plasma Fractionation Market Outlook, By Critical Care (2014-2023) ($MN)
Table 59 North America Plasma Fractionation Market Outlook, By Hematology (2014-2023) ($MN)
Table 60 North America Plasma Fractionation Market Outlook, By Other Applications (2014-2023) ($MN)
Table 61 Europe Plasma Fractionation Market Outlook, By Country (2014-2023) ($MN)
Table 62 Europe Plasma Fractionation Market Outlook, By Product (2014-2023) ($MN)
Table 63 Europe Plasma Fractionation Market Outlook, By Protease Inhibitors (2014-2023) ($MN)
Table 64 Europe Plasma Fractionation Market Outlook, By Coagulation Factor Concentrates (2014-2023) ($MN)
Table 65 Europe Plasma Fractionation Market Outlook, By Factor VIII (2014-2023) ($MN)
Table 66 Europe Plasma Fractionation Market Outlook, By Factor IX (2014-2023) ($MN)
Table 67 Europe Plasma Fractionation Market Outlook, By Factor XIII (2014-2023) ($MN)
Table 68 Europe Plasma Fractionation Market Outlook, By Fibrinogen Concentrates (2014-2023) ($MN)
Table 69 Europe Plasma Fractionation Market Outlook, By Prothrombin Complex Concentrates (2014-2023) ($MN)
Table 70 Europe Plasma Fractionation Market Outlook, By Von Willebrand Factor (VWF) (2014-2023) ($MN)
Table 71 Europe Plasma Fractionation Market Outlook, By Immunoglobulin (2014-2023) ($MN)
Table 72 Europe Plasma Fractionation Market Outlook, By Subcutaneous Immunoglobulin (2014-2023) ($MN)
Table 73 Europe Plasma Fractionation Market Outlook, By Intravenous Immunoglobulin (2014-2023) ($MN)
Table 74 Europe Plasma Fractionation Market Outlook, By Other Immunoglobulins (2014-2023) ($MN)
Table 75 Europe Plasma Fractionation Market Outlook, By Fractionation Process (2014-2023) ($MN)
Table 76 Europe Plasma Fractionation Market Outlook, By Albumin (2014-2023) ($MN)
Table 77 Europe Plasma Fractionation Market Outlook, By Other Plasma Products (2014-2023) ($MN)
Table 78 Europe Plasma Fractionation Market Outlook, By End User (2014-2023) ($MN)
Table 79 Europe Plasma Fractionation Market Outlook, By Clinical Research Laboratories (2014-2023) ($MN)
Table 80 Europe Plasma Fractionation Market Outlook, By Academic Institutes (2014-2023) ($MN)
Table 81 Europe Plasma Fractionation Market Outlook, By Hospitals and Clinics (2014-2023) ($MN)
Table 82 Europe Plasma Fractionation Market Outlook, By Application (2014-2023) ($MN)
Table 83 Europe Plasma Fractionation Market Outlook, By Rheumatology (2014-2023) ($MN)
Table 84 Europe Plasma Fractionation Market Outlook, By Pulmonology (2014-2023) ($MN)
Table 85 Europe Plasma Fractionation Market Outlook, By Hemato-Oncology (2014-2023) ($MN)
Table 86 Europe Plasma Fractionation Market Outlook, By Immunology (2014-2023) ($MN)
Table 87 Europe Plasma Fractionation Market Outlook, By Neurology (2014-2023) ($MN)
Table 88 Europe Plasma Fractionation Market Outlook, By Critical Care (2014-2023) ($MN)
Table 89 Europe Plasma Fractionation Market Outlook, By Hematology (2014-2023) ($MN)
Table 90 Europe Plasma Fractionation Market Outlook, By Other Applications (2014-2023) ($MN)
Table 91 Asia Pacific Plasma Fractionation Market Outlook, By Country (2014-2023) ($MN)
Table 92 Asia Pacific Plasma Fractionation Market Outlook, By Product (2014-2023) ($MN)
Table 93 Asia Pacific Plasma Fractionation Market Outlook, By Protease Inhibitors (2014-2023) ($MN)
Table 94 Asia Pacific Plasma Fractionation Market Outlook, By Coagulation Factor Concentrates (2014-2023) ($MN)
Table 95 Asia Pacific Plasma Fractionation Market Outlook, By Factor VIII (2014-2023) ($MN)
Table 96 Asia Pacific Plasma Fractionation Market Outlook, By Factor IX (2014-2023) ($MN)
Table 97 Asia Pacific Plasma Fractionation Market Outlook, By Factor XIII (2014-2023) ($MN)
Table 98 Asia Pacific Plasma Fractionation Market Outlook, By Fibrinogen Concentrates (2014-2023) ($MN)
Table 99 Asia Pacific Plasma Fractionation Market Outlook, By Prothrombin Complex Concentrates (2014-2023) ($MN)
Table 100 Asia Pacific Plasma Fractionation Market Outlook, By Von Willebrand Factor (VWF) (2014-2023) ($MN)
Table 101 Asia Pacific Plasma Fractionation Market Outlook, By Immunoglobulin (2014-2023) ($MN)
Table 102 Asia Pacific Plasma Fractionation Market Outlook, By Subcutaneous Immunoglobulin (2014-2023) ($MN)
Table 103 Asia Pacific Plasma Fractionation Market Outlook, By Intravenous Immunoglobulin (2014-2023) ($MN)
Table 104 Asia Pacific Plasma Fractionation Market Outlook, By Other Immunoglobulins (2014-2023) ($MN)
Table 105 Asia Pacific Plasma Fractionation Market Outlook, By Fractionation Process (2014-2023) ($MN)
Table 106 Asia Pacific Plasma Fractionation Market Outlook, By Albumin (2014-2023) ($MN)
Table 107 Asia Pacific Plasma Fractionation Market Outlook, By Other Plasma Products (2014-2023) ($MN)
Table 108 Asia Pacific Plasma Fractionation Market Outlook, By End User (2014-2023) ($MN)
Table 109 Asia Pacific Plasma Fractionation Market Outlook, By Clinical Research Laboratories (2014-2023) ($MN)
Table 110 Asia Pacific Plasma Fractionation Market Outlook, By Academic Institutes (2014-2023) ($MN)
Table 111 Asia Pacific Plasma Fractionation Market Outlook, By Hospitals and Clinics (2014-2023) ($MN)
Table 112 Asia Pacific Plasma Fractionation Market Outlook, By Application (2014-2023) ($MN)
Table 113 Asia Pacific Plasma Fractionation Market Outlook, By Rheumatology (2014-2023) ($MN)
Table 114 Asia Pacific Plasma Fractionation Market Outlook, By Pulmonology (2014-2023) ($MN)
Table 115 Asia Pacific Plasma Fractionation Market Outlook, By Hemato-Oncology (2014-2023) ($MN)
Table 116 Asia Pacific Plasma Fractionation Market Outlook, By Immunology (2014-2023) ($MN)
Table 117 Asia Pacific Plasma Fractionation Market Outlook, By Neurology (2014-2023) ($MN)
Table 118 Asia Pacific Plasma Fractionation Market Outlook, By Critical Care (2014-2023) ($MN)
Table 119 Asia Pacific Plasma Fractionation Market Outlook, By Hematology (2014-2023) ($MN)
Table 120 Asia Pacific Plasma Fractionation Market Outlook, By Other Applications (2014-2023) ($MN)
Table 121 South America Plasma Fractionation Market Outlook, By Country (2014-2023) ($MN)
Table 122 South America Plasma Fractionation Market Outlook, By Product (2014-2023) ($MN)
Table 123 South America Plasma Fractionation Market Outlook, By Protease Inhibitors (2014-2023) ($MN)
Table 124 South America Plasma Fractionation Market Outlook, By Coagulation Factor Concentrates (2014-2023) ($MN)
Table 125 South America Plasma Fractionation Market Outlook, By Factor VIII (2014-2023) ($MN)
Table 126 South America Plasma Fractionation Market Outlook, By Factor IX (2014-2023) ($MN)
Table 127 South America Plasma Fractionation Market Outlook, By Factor XIII (2014-2023) ($MN)
Table 128 South America Plasma Fractionation Market Outlook, By Fibrinogen Concentrates (2014-2023) ($MN)
Table 129 South America Plasma Fractionation Market Outlook, By Prothrombin Complex Concentrates (2014-2023) ($MN)
Table 130 South America Plasma Fractionation Market Outlook, By Von Willebrand Factor (VWF) (2014-2023) ($MN)
Table 131 South America Plasma Fractionation Market Outlook, By Immunoglobulin (2014-2023) ($MN)
Table 132 South America Plasma Fractionation Market Outlook, By Subcutaneous Immunoglobulin (2014-2023) ($MN)
Table 133 South America Plasma Fractionation Market Outlook, By Intravenous Immunoglobulin (2014-2023) ($MN)
Table 134 South America Plasma Fractionation Market Outlook, By Other Immunoglobulins (2014-2023) ($MN)
Table 135 South America Plasma Fractionation Market Outlook, By Fractionation Process (2014-2023) ($MN)
Table 136 South America Plasma Fractionation Market Outlook, By Albumin (2014-2023) ($MN)
Table 137 South America Plasma Fractionation Market Outlook, By Other Plasma Products (2014-2023) ($MN)
Table 138 South America Plasma Fractionation Market Outlook, By End User (2014-2023) ($MN)
Table 139 South America Plasma Fractionation Market Outlook, By Clinical Research Laboratories (2014-2023) ($MN)
Table 140 South America Plasma Fractionation Market Outlook, By Academic Institutes (2014-2023) ($MN)
Table 141 South America Plasma Fractionation Market Outlook, By Hospitals and Clinics (2014-2023) ($MN)
Table 142 South America Plasma Fractionation Market Outlook, By Application (2014-2023) ($MN)
Table 143 South America Plasma Fractionation Market Outlook, By Rheumatology (2014-2023) ($MN)
Table 144 South America Plasma Fractionation Market Outlook, By Pulmonology (2014-2023) ($MN)
Table 145 South America Plasma Fractionation Market Outlook, By Hemato-Oncology (2014-2023) ($MN)
Table 146 South America Plasma Fractionation Market Outlook, By Immunology (2014-2023) ($MN)
Table 147 South America Plasma Fractionation Market Outlook, By Neurology (2014-2023) ($MN)
Table 148 South America Plasma Fractionation Market Outlook, By Critical Care (2014-2023) ($MN)
Table 149 South America Plasma Fractionation Market Outlook, By Hematology (2014-2023) ($MN)
Table 150 South America Plasma Fractionation Market Outlook, By Other Applications (2014-2023) ($MN)
Table 151 Middle East & Africa Plasma Fractionation Market Outlook, By Country (2014-2023) ($MN)
Table 152 Middle East & Africa Plasma Fractionation Market Outlook, By Product (2014-2023) ($MN)
Table 153 Middle East & Africa Plasma Fractionation Market Outlook, By Protease Inhibitors (2014-2023) ($MN)
Table 154 Middle East & Africa Plasma Fractionation Market Outlook, By Coagulation Factor Concentrates (2014-2023) ($MN)
Table 155 Middle East & Africa Plasma Fractionation Market Outlook, By Factor VIII (2014-2023) ($MN)
Table 156 Middle East & Africa Plasma Fractionation Market Outlook, By Factor IX (2014-2023) ($MN)
Table 157 Middle East & Africa Plasma Fractionation Market Outlook, By Factor XIII (2014-2023) ($MN)
Table 158 Middle East & Africa Plasma Fractionation Market Outlook, By Fibrinogen Concentrates (2014-2023) ($MN)
Table 159 Middle East & Africa Plasma Fractionation Market Outlook, By Prothrombin Complex Concentrates (2014-2023) ($MN)
Table 160 Middle East & Africa Plasma Fractionation Market Outlook, By Von Willebrand Factor (VWF) (2014-2023) ($MN)
Table 161 Middle East & Africa Plasma Fractionation Market Outlook, By Immunoglobulin (2014-2023) ($MN)
Table 162 Middle East & Africa Plasma Fractionation Market Outlook, By Subcutaneous Immunoglobulin (2014-2023) ($MN)
Table 163 Middle East & Africa Plasma Fractionation Market Outlook, By Intravenous Immunoglobulin (2014-2023) ($MN)
Table 164 Middle East & Africa Plasma Fractionation Market Outlook, By Other Immunoglobulins (2014-2023) ($MN)
Table 165 Middle East & Africa Plasma Fractionation Market Outlook, By Fractionation Process (2014-2023) ($MN)
Table 166 Middle East & Africa Plasma Fractionation Market Outlook, By Albumin (2014-2023) ($MN)
Table 167 Middle East & Africa Plasma Fractionation Market Outlook, By Other Plasma Products (2014-2023) ($MN)
Table 168 Middle East & Africa Plasma Fractionation Market Outlook, By End User (2014-2023) ($MN)
Table 169 Middle East & Africa Plasma Fractionation Market Outlook, By Clinical Research Laboratories (2014-2023) ($MN)
Table 170 Middle East & Africa Plasma Fractionation Market Outlook, By Academic Institutes (2014-2023) ($MN)
Table 171 Middle East & Africa Plasma Fractionation Market Outlook, By Hospitals and Clinics (2014-2023) ($MN)
Table 172 Middle East & Africa Plasma Fractionation Market Outlook, By Application (2014-2023) ($MN)
Table 173 Middle East & Africa Plasma Fractionation Market Outlook, By Rheumatology (2014-2023) ($MN)
Table 174 Middle East & Africa Plasma Fractionation Market Outlook, By Pulmonology (2014-2023) ($MN)
Table 175 Middle East & Africa Plasma Fractionation Market Outlook, By Hemato-Oncology (2014-2023) ($MN)
Table 176 Middle East & Africa Plasma Fractionation Market Outlook, By Immunology (2014-2023) ($MN)
Table 177 Middle East & Africa Plasma Fractionation Market Outlook, By Neurology (2014-2023) ($MN)
Table 178 Middle East & Africa Plasma Fractionation Market Outlook, By Critical Care (2014-2023) ($MN)
Table 179 Middle East & Africa Plasma Fractionation Market Outlook, By Hematology (2014-2023) ($MN)
Table 180 Middle East & Africa Plasma Fractionation Market Outlook, By Other Applications (2014-2023) ($MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Octapharma AG
  • Chinese Biological Products, Inc.
  • Bio Products Laboratory
  • Baxter International, Inc.
  • Csl, Ltd.
  • Grifols International SA
  • Shanghai Raas Blood Products Co., Ltd
  • China Biologic Products, Inc.
  • Biotest
  • Kedrion S.P.A.
  • LFB SA
  • Sanquin
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll